264 related articles for article (PubMed ID: 33065064)
1. Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.
Melmed GY; Rubin DT; McGovern DPB
Gastroenterology; 2021 Feb; 160(3):639-644. PubMed ID: 33065064
[No Abstract] [Full Text] [Related]
2. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
Selim R; Wellens J; Marlow L; Satsangi JJ
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):989. PubMed ID: 34655528
[No Abstract] [Full Text] [Related]
4. Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
Alexander JL; Selinger CP; Powell N;
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):987-988. PubMed ID: 34653395
[No Abstract] [Full Text] [Related]
5. Parents' intent to vaccinate against influenza during the COVID-19 pandemic in two regions in Switzerland.
Seiler M; Goldman RD; Staubli G; Hoeffe J; Gualco G; Manzano S; Part Of The International Covid-Parental Attitude Study Covipas Group
Swiss Med Wkly; 2021 May; 151():w20508. PubMed ID: 34002802
[TBL] [Abstract][Full Text] [Related]
6. Sub-optimal H1N1 vaccine uptake by immunocompromised inflammatory bowel disease patients.
Hanna M; Poullis A
Clin Med (Lond); 2011 Jun; 11(3):301. PubMed ID: 21902095
[No Abstract] [Full Text] [Related]
7. H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy.
Rahier JF; Papay P; Salleron J; Sebastian S; Marzo M; Peyrin-Biroulet L; Garcia-Sanchez V; Fries W; van Asseldonk DP; Farkas K; de Boer NK; Sipponen T; Ellul P; Louis E; Peake ST; Kopylov U; Maul J; Makhoul B; Fiorino G; Yazdanpanah Y; Chaparro M;
Gut; 2011 Apr; 60(4):456-62. PubMed ID: 21270121
[TBL] [Abstract][Full Text] [Related]
8. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.
Matsumoto H; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
J Gastroenterol; 2015 Aug; 50(8):876-86. PubMed ID: 25672513
[TBL] [Abstract][Full Text] [Related]
9. Influenza Virus and SARS-CoV-2 Vaccines.
Sandor AM; Sturdivant MS; Ting JPY
J Immunol; 2021 Jun; 206(11):2509-2520. PubMed ID: 34021048
[TBL] [Abstract][Full Text] [Related]
10. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.
Törüner M; Kalkan İH; Akyüz F; Tezel A; Çelik AF
Turk J Gastroenterol; 2021 Jun; 32(6):488-492. PubMed ID: 34405814
[TBL] [Abstract][Full Text] [Related]
11. [The efficiency of influenza vaccines in patients with inflammatory bowel disease on immunosuppressive therapy].
Farkas K; Terhes G; Deák J; Bálint A; Nagy F; Szepes Z; Wittmann T; Molnár T
Orv Hetil; 2012 Nov; 153(47):1870-4. PubMed ID: 23160078
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States.
Hadi YB; Thakkar S; Shah-Khan SM; Hutson W; Sarwari A; Singh S
Gastroenterology; 2021 Oct; 161(4):1336-1339.e3. PubMed ID: 34144044
[No Abstract] [Full Text] [Related]
13. Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response.
Ruscio BA; Hotez P
Vaccine; 2020 Nov; 38(50):7880-7882. PubMed ID: 33121842
[TBL] [Abstract][Full Text] [Related]
14. BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
Andrews N; Stowe J; Miller E; Ramsay M
JAMA; 2023 Jul; 330(2):184-185. PubMed ID: 37318811
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
Walldorf J; von Arnim U; Schmelz R; Riesner-Wehner A; Michl P; Grunert PC; Stallmach A; Teich N; Reuken PA
Inflamm Bowel Dis; 2021 Oct; 27(11):1858-1861. PubMed ID: 34181021
[No Abstract] [Full Text] [Related]
16. SARS-CoV-2 vaccination in IBD: more pros than cons.
D'Amico F; Rabaud C; Peyrin-Biroulet L; Danese S
Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):211-213. PubMed ID: 33473178
[TBL] [Abstract][Full Text] [Related]
17. A practical guide to vaccinating the inflammatory bowel disease patient.
Wasan SK; Baker SE; Skolnik PR; Farraye FA
Am J Gastroenterol; 2010 Jun; 105(6):1231-8. PubMed ID: 20104218
[TBL] [Abstract][Full Text] [Related]
18. Appropriate response to influenza A (H1N1) virus vaccination in patients with inflammatory bowel disease on maintenance immunomodulator and/or biological therapy.
Molnár T; Farkas K; Jankovics I; Melles M; Nagy F; Szepes Z; Wittmann T
Am J Gastroenterol; 2011 Feb; 106(2):370-2. PubMed ID: 21301464
[No Abstract] [Full Text] [Related]
19. The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
Rubin R
JAMA; 2022 Oct; 328(15):1488-1489. PubMed ID: 36129724
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Quadrivalent Influenza Vaccine for Patients with Inflammatory Bowel Disease Undergoing Immunosuppressive Therapy.
Shirai S; Hara M; Sakata Y; Tsuruoka N; Yamamoto K; Shimoda R; Gomi Y; Yoshii H; Fujimoto K; Iwakiri R
Inflamm Bowel Dis; 2018 Apr; 24(5):1082-1091. PubMed ID: 29538682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
